The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis.

EClinicalMedicine · 2023 · PMC9874016 · PMID 36713467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In PALOMA-3, 42 the final pre-specified survival analysis did not reach statistical significance and in the recently reported PALOMA-2 analysis OS advantage was non-significant, 23 with a high percentage of missing data.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.